KPT Industries re-appoints three independent directors for five-year terms

2 min read     Updated on 08 Aug 2026, 02:10 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

KPT Industries Ltd re-appointed Sanjay Ramakant Buch, Niraj Shishir Shirgaokar, and Rama Sanjay Kirloskar as independent directors for a second five-year term on August 08, 2026. The approvals followed shareholder resolution and compliance with SEBI LODR Regulations and the Companies Act, 2013. The directors bring specialized expertise in law, sugar manufacturing, and engineering to enhance Board governance.

powered bylight_fuzz_icon
47724005

*this image is generated using AI for illustrative purposes only.

KPT Industries Ltd kpt industries shareholders approved the re-appointment of Sanjay Ramakant Buch, Niraj Shishir Shirgaokar, and Rama Sanjay Kirloskar as independent directors on August 08, 2026. The resolution passed at the meeting grants each director a second term of five consecutive years, reinforcing the Board’s composition with experienced professionals in legal, industrial, and engineering sectors. This governance update ensures continuity in oversight and strategic guidance for the company.

The appointments comply with Section 149 and Section 152 of the Companies Act, 2013, along with Schedule IV and Regulation 17(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company notified BSE Limited pursuant to Regulation 30(6) read with Part A Para A of Schedule III of the SEBI LODR Regulations. All three directors have provided declarations confirming their independence under Section 149(6) of the Act and Regulation 16(1)(b) of the SEBI LODR Regulations, 2015, and are not disqualified under Section 164 of the Companies Act.

Director Profiles

The Nomination and Remuneration Committee recommended these appointments based on professional credentials and expertise. The directors bring diverse industry experience to the Board:

Director Name DIN Key Professional Background
Sanjay Ramakant Buch 00391436 Senior Advocate & Solicitor; Partner at Crawford Bayley & Co.
Niraj Shishir Shirgaokar 00254525 Managing Director, Ugar Sugar Works Ltd.; Former President, ISMA
Rama Sanjay Kirloskar 07474724 Joint Managing Director, Kirloskar Brothers Limited; MD, KEPL

Sanjay Ramakant Buch is a Senior Advocate and Solicitor practicing in Mumbai for over three decades. He specializes in business and corporate laws, mergers and acquisitions, securities regulations, and arbitration. He serves as a legal advisor to multinational companies and holds independent director positions in other reputed firms.

Niraj Shishir Shirgaokar holds a Bachelor’s Degree in Computer Engineering from Bombay University and has 15 years of experience in multinational companies. He is the Managing Director of The Ugar Sugar Works Ltd., part of the Shirgaokar Group of Companies with interests in sugar, power, ethanol, IMFL, foundries, and IT. He co-founded iResearch Services Pvt. Ltd. in 2008 and has served as President of both the South India Sugar Mills Association (SISMA) and the India Sugar Mills Association (ISMA). He is also an accomplished squash player, having represented India at the World Open Squash Doubles Championship.

Rama Sanjay Kirloskar holds a double major in Mathematics and Biology from Bryn Mawr College, USA. She is the Joint Managing Director of Kirloskar Brothers Limited (KBL) and Managing Director of Kirloskar Ebara Pumps Limited (KEPL), a joint venture with Ebara Corporation, Japan. She serves on the boards of Karad Projects and Motors Limited and Prakar Investments Private Limited. Additionally, she is on the Executive Council of Accelerating Growth of New India's Innovations (AGNII), a program under the Office of the Principal Scientific Adviser to the Government of India and the Prime Minister’s Science Technology and Innovation Advisory Council (PM-STIAC).

Governance Implications

The re-appointment strengthens the independent oversight capability of the Board by retaining directors with deep sector-specific knowledge. Buch’s legal expertise supports regulatory compliance and corporate governance, while Shirgaokar’s industrial leadership offers insights into manufacturing and supply chain dynamics. Kirloskar’s engineering and innovation background aligns with technological advancement strategies. The five-year tenure allows for long-term strategic planning without frequent leadership transitions.

Historical Stock Returns for KPT Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+3.08%+5.75%-13.23%-10.67%-35.72%+275.76%

How might the retention of Sanjay Ramakant Buch's legal expertise influence KPT Industries' approach to upcoming regulatory changes in corporate governance?

What specific strategic initiatives could Rama Sanjay Kirloskar's background in engineering and innovation drive for KPT Industries over the next five years?

Will Niraj Shishir Shirgaokar's extensive experience in the sugar and power sectors lead to new supply chain partnerships or vertical integrations for KPT Industries?

KPT Industries regularizes Dr. Nitin Pai as Non-Executive Director

1 min read     Updated on 08 Aug 2026, 02:03 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

KPT Industries Ltd has regularized the appointment of Dr. Nitin Vikas Pai as a Non-Executive Director after shareholder approval on August 8, 2026. His term began on May 29, 2026, and he is liable to retire by rotation. Dr. Pai is a senior gastroenterologist and nephew to the Non-Executive Chairperson, Mrs. Prabha Kulkarni. The move complies with SEBI LODR regulations.

powered bylight_fuzz_icon
47723620

*this image is generated using AI for illustrative purposes only.

KPT Industries Limited KPT Industries has regularized the appointment of Dr. Nitin Vikas Pai as a Non-Executive Director, confirming his position on the Board. Shareholders approved the regularization via a resolution passed at their meeting held on August 8, 2026. This action finalizes the governance structure for the new director, who is liable to retire by rotation.

The regularization was undertaken pursuant to Regulation 30(6), read with Schedule III Part A Para A, of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company notified BSE Limited of the development on August 8, 2026, ensuring compliance with listing obligations regarding changes in board composition.

Director Profile and Tenure

Dr. Nitin Vikas Pai’s appointment as Non-Executive Director became effective on May 29, 2026. At 52 years of age, he brings significant professional credentials to the role. His educational background includes an MD in Medicine, DNB in Medicine, and a DM in Gastroenterology. Professionally, he serves as a senior gastroenterologist based in Pune and holds the position of Director of Gastroenterology at Ruby Hall Clinic, a prominent tertiary care institution in the region.

Detail Information
Name Dr. Nitin Vikas Pai
Role Non-Executive Director
Appointment Date May 29, 2026
Regularization Date August 8, 2026
Retirement Status Liable to retire by rotation

Disclosures and Relationships

In accordance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, the company disclosed specific relationships involving the newly appointed director. Dr. Nitin Pai is the nephew of Late Mr. Prakash Kulkarni and Mrs. Prabha Kulkarni, who serves as the Non-Executive Chairperson. He is also the brother of Dr. Ketan Vikas Pai.

The filing confirms that Dr. Pai does not fall under the purview of Section 2(76) or Section 2(77) of the Companies Act, indicating no disqualifying conditions apply. Furthermore, the company stated that he is not debarred from holding office by any regulatory authority. Aishwarya Toraskar, Company Secretary & Compliance Officer (ACS 54931), signed the intimation.

Historical Stock Returns for KPT Industries

1 Day5 Days1 Month6 Months1 Year5 Years
+3.08%+5.75%-13.23%-10.67%-35.72%+275.76%

How might Dr. Pai's medical expertise influence KPT Industries' strategic decisions regarding healthcare sector investments or ESG compliance?

Given the familial relationship with the Non-Executive Chairperson, what specific safeguards will the board implement to ensure independent oversight and mitigate conflict of interest risks?

Will the addition of a Non-Executive Director with a healthcare background signal a potential pivot or expansion of KPT Industries into the medical services or pharmaceutical supply chain sectors?

More News on KPT Industries

1 Year Returns:-35.72%